BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 9658724)

  • 1. Conventional cytogenetics and FISH evaluation of chimerism after sex-mismatched bone marrow transplantation (BMT) and donor leukocyte infusion (DLI).
    Díez-Martín JL; Llamas P; Gosálvez J; López-Fernández C; Polo N; de la Fuente MS; Buño I
    Haematologica; 1998 May; 83(5):408-15. PubMed ID: 9658724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FISH analysis of native smears from bone marrow and blood for the monitoring of chimerism and clonal markers after stem cell transplantation in children.
    Fuehrer M; Gerusel-Bleck M; Konstantopoulos N; Bender-Goetze C; Walther JU
    Int J Mol Med; 2005 Feb; 15(2):291-7. PubMed ID: 15647846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of chimerism in subpopulations of cells by fluorescence in situ hybridization and immunofluorescent staining of cell surface antigens.
    Gerritsen WR; Jagiello CA; Bourhis JH
    Bone Marrow Transplant; 1994 Apr; 13(4):441-7. PubMed ID: 8019469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescent in situ hybridization on flow-sorted cells as a tool for evaluating minimal residual disease or chimerism after allogenic bone marrow transplantation.
    Cotteret S; Belloc F; Boiron JM; Bilhou-Nabera C; Dumain P; Boyer C; Lacombe F; Reiffers J; Bernard P
    Cytometry; 1998 Oct; 34(5):216-22. PubMed ID: 9822307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of mixed chimerism and leukemic relapse after allogeneic bone marrow transplantation in subpopulations of leucocytes by fluorescent in situ hybridization in combination with the simultaneous immunophenotypic analysis of interphase cells.
    Kögler G; Wolf HH; Heyll A; Arkesteijn G; Wernet P
    Bone Marrow Transplant; 1995 Jan; 15(1):41-8. PubMed ID: 7742754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms for the size of heterochromatic regions allow sex-independent quantification of post-BMT chimerism targeting metaphase and interphase cells.
    Buño I; Díez-Martín JL; López-Fernández C; Fernández JL; Gosálvez J
    Haematologica; 1999 Feb; 84(2):138-41. PubMed ID: 10091412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Application of sequential and quantitative monitoring of chimerism in allogeneic hematopoietic stem cell transplantation].
    Tang XW; Wu DP; Zhu ZL; Wang W; Sun AN; Qiu HY; Fu ZZ; Chang WR; Ruan CG
    Zhonghua Xue Ye Xue Za Zhi; 2004 Feb; 25(2):78-81. PubMed ID: 14990044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study of the time course of mixed chimerism by fluorescent in situ hybridization in patients with chronic myeloid leukemia after allogenic transplantation of bone marrow].
    Vinogradova OA; Savchenko VG; Neverova AL; Diachenko LV; Domracheva EV; Liubimova LS; Mendeleeva LP
    Ter Arkh; 2001; 73(7):26-34. PubMed ID: 11523405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative analysis of chimerism after allogeneic stem cell transplantation by real-time polymerase chain reaction with single nucleotide polymorphisms, standard tandem repeats, and Y-chromosome-specific sequences.
    Koldehoff M; Steckel NK; Hlinka M; Beelen DW; Elmaagacli AH
    Am J Hematol; 2006 Oct; 81(10):735-46. PubMed ID: 16838323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor/recipient mixed chimerism does not predict graft failure in children with beta-thalassemia given an allogeneic cord blood transplant from an HLA-identical sibling.
    Lisini D; Zecca M; Giorgiani G; Montagna D; Cristantielli R; Labirio M; Grignani P; Previderè C; Di Cesare-Merlone A; Amendola G; Bergami E; Mastronuzzi A; Maccario R; Locatelli F
    Haematologica; 2008 Dec; 93(12):1859-67. PubMed ID: 18945748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of fluorescent in situ hybridization and multiplex short tandem repeat polymerase chain reaction for quantifying chimerism after stem cell transplantation.
    Buño I; Nava P; Simón A; González-Rivera M; Jiménez JL; Balsalobre P; Serrano D; Carrión R; Gómez-Pineda A; Díez-Martín JL
    Haematologica; 2005 Oct; 90(10):1373-9. PubMed ID: 16219574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of residual host cells after bone marrow transplantation using non-isotopic in situ hybridization and karyotype analysis.
    Wessman M; Popp S; Ruutu T; Volin L; Cremer T; Knuutila S
    Bone Marrow Transplant; 1993 Apr; 11(4):279-84. PubMed ID: 8485475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential molecular monitoring of chimerism in chronic myeloid leukemia patients receiving donor lymphocyte transfusion for relapse after bone marrow transplantation.
    Rapanotti MC; Arcese W; Buffolino S; Iori AP; Mengarelli A; De Cuia MR; Cardillo A; Cimino G
    Bone Marrow Transplant; 1997 Apr; 19(7):703-7. PubMed ID: 9156248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interphase FISH analysis of sex-mismatched BMT utilizing dual color XY probes.
    Najfeld V; Burnett W; Vlachos A; Scigliano E; Isola L; Fruchtman S
    Bone Marrow Transplant; 1997 Apr; 19(8):829-34. PubMed ID: 9134177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donor chimerism does not predict response to donor lymphocyte infusion for relapsed chronic myelogenous leukemia after allogeneic hematopoietic cell transplantation.
    Chiorean EG; DeFor TE; Weisdorf DJ; Blazar BR; McGlave PB; Burns LJ; Brown C; Miller JS
    Biol Blood Marrow Transplant; 2004 Mar; 10(3):171-7. PubMed ID: 14993882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative Study of FISH, PCR and Cytogenetics on 25 Patients Submitted to Bone Marrow Transplantation (BMT) for Chronic Myelogenous Leukemia (CML); Which Tests can we Use in Routine Analysis Post BMT?
    Palka G; Lawler M; Morizio E; Gardiner N; Stuppia L; De Arce MA; Di Bartolomeo PD; Capodiferro F; Sabatino G; Gatta V; Calabrese G; Cann SR
    Hematology; 1998; 3(3):193-203. PubMed ID: 27416528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Graft-versus-leukemia effects from donor lymphocyte infusion after nonmyeloablative allogeneic bone marrow transplantation in mice.
    Du B; Li DP; Xu KL; Pan XY
    Chin Med J (Engl); 2005 Mar; 118(6):474-9. PubMed ID: 15788128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor leukocyte infusions for recurrent hematologic malignancies after allogeneic bone marrow transplantation: impact of infused and residual donor T cells.
    Verdonck LF; Petersen EJ; Lokhorst HM; Nieuwenhuis HK; Dekker AW; Tilanus MG; de Weger RA
    Bone Marrow Transplant; 1998 Dec; 22(11):1057-63. PubMed ID: 9877267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous detection of X and Y chromosomes by two-colour fluorescence in situ hybridization in combination with immunophenotyping of single cells to document chimaerism after sex-mismatched bone marrow transplantation.
    van Tol MJ; Langlois van den Bergh R; Mesker W; Ouwerkerk-van Velzen MC; Vossen JM; Tanke HJ
    Bone Marrow Transplant; 1998 Mar; 21(5):497-503. PubMed ID: 9535042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FISH detection of chimerism in pediatric hematopoietic stem cell transplantation.
    Aydin F; Oguz F; Onal AE; Bilgen H; Oguz R; Anak S; Carin M; Gedikoglu G
    Int J Lab Hematol; 2007 Jun; 29(3):208-14. PubMed ID: 17474899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.